Dama Health

What Dama Health does

Dama Health is a London-based health technology company founded in 2021 that builds AI-powered clinical decision support tools for personalized hormone prescribing in women's health. The company's core platform analyzes over 150 phenotypic data points per patient and integrates pharmacogenomic insights, clinical guidelines, and proprietary medical consensus documents to help clinicians navigate contraception, perimenopause, and menopause care. Key products include Dama Assist (an AI assistant trained specifically on clinical guidelines), the Hormone & Menstrual Health Assessment, branded Patient Funnels, a free Rx Checker tool, and a Patient Monitoring & Engagement module with e-fax/EMR integration. The company has built one of the largest multi-modal clinical-grade datasets on hormonal contraceptive use, response, and side effects through its Genetics of Contraception Study, which recruited 1,138 women across the UK with full-genome sequencing on over 600 patients.

Dama Health operates a B2B enterprise SaaS model targeting OB/GYNs, nurse practitioners, primary care providers, and women's health clinics via a "Book a Demo" sales motion and integration into existing clinical workflows. Revenue streams include platform licensing/subscriptions for healthcare practices, professional services (evidence-based prescribing protocols available via API, custom tech solutions), and research/bioinformatics services for academic institutions. Consumer-facing tools (Dama Assist, Rx Checker) serve as top-of-funnel lead generation. The company is at late seed stage with 1-10 employees, has received an ARPA-H Sprint for Women's Health award as part of the EMMA consortium ($3M over two years), and is expanding into the US market with a planned headquarters in Philadelphia.

Name

Dama Health

Legal name

Dama Health Ltd.

Website

https://damahealth.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Dama Health is a London-based healthtech company that provides AI-powered clinical decision support and pharmacogenomics tools to OB/GYNs and women's health clinics for personalized hormone prescribing across contraception, perimenopause, and menopause care.

Ownership category

akta.pro rank

Product category

Women's Health Clinical Decision Support Software

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Pharmacogenomics (PGx) Decision Support (HLAAANAB)

akta.pro secondary industries

Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management) (HLALAFAL), Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)

Keywords

• Women's health software
• Clinical decision support
• Hormone therapy prescribing
• Pharmacogenomic analysis
• Fertility care platform

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Platform Licensing / SaaS: Dama Health provides its clinical platform to healthcare and wellness practices. The platform includes patient assessment tools, clinical decision support, and reporting modules. The company offers a 'Book a Demo' CTA suggesting a direct sales motion for practice-level licensing.
2. Professional Services: Expert advice, evidence-based prescribing protocols, and clinical consultation services available for purchase, customization, or integration. Tech-enabled solution design and build services. Research and bioinformatics support for organizations designing women's health studies.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Dama Health provides an AI-powered clinical decision support platform for personalized hormone prescribing in women's health, combining phenotypic data (150+ data points per patient), pharmacogenomic analysis, and evidence-based clinical guidelines. The platform serves healthcare and wellness practices with branded patient lead funnels, pre-visit assessments, an intelligent recommendation engine, and ongoing patient monitoring for contraception, perimenopause, menopause, and endometriosis care.

Product overview

Dama Health offers a unified clinical intelligence platform for personalized, evidence-based women’s health. The core offering includes Dama Assist (AI-powered clinical decision support for hormone care), the Hormone & Menstrual Health Assessment (analyzing 150+ patient data points), Patient Funnel (branded lead-generation assessments), Rx Checker (contraceptive lookup tool), and Patient Monitoring & Engagement (intelligent follow-up for hormone therapies). Supporting services include evidence-based prescribing protocols (available via API), custom tech solutions for women’s health, study design collaboration with Yale, and end-to-end genetics study execution. The company also participates in the EMMA consortium for endometriosis research through ARPA-H funding.

Differentiator

Problem solved

Functional benefit

Brands

• Dama Assist: AI tool designed to help clinicians navigate hormone care for conditions spanning contraception, perimenopause, and menopause. Built using clinical guidelines, medication databases, and proprietary medical consensus documents.

Products and services

• Dama Assist AI-powered clinical decision support tool that helps clinicians navigate hormone care for contraception, perimenopause, and menopause. Specifically trained using clinical guidelines, medication databases, and proprietary medical consensus documents, addressing a gap where general LLMs achieved only around 67% accuracy on menopause-related clinical questions.
• Hormone & Menstrual Health Assessment

Quantifiable outcome

• 201 patients completed contraceptive assessment with 40.5% sign-up rate in feasibility pilot
• +7 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability7 records

Feature8 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Nura HealthcoreStrategic or Co-development Partner · 23 October 2024Dama Health is a consortium partner with Nura Health in the EMMA (Endometriosis Multimodal Management Application) project, funded by ARPA-H's Sprint for Women's Health ($3M award). Nura Health contributes molecular-diagnostics expertise. Dama Health leads the pharmacogenomics and biomarker-integration workstream.
• Lasa HealthcoreStrategic or Co-development Partner · 23 October 2024Dama Health is a consortium partner with Lasa Health in the EMMA project, funded by ARPA-H's Sprint for Women's Health ($3M award). Lasa Health provides digital phenotyping and patient-engagement infrastructure. Together with Nura Health, the consortium is developing a precision medicine platform for endometriosis diagnosis and treatment.
• IlluminacoreStrategic or Co-development PartnerDama Health was accepted into the Illumina Accelerator program. This partnership supported the Genetics of Contraception Study, which recruited 1,138 women across the UK with full-genome data sequenced on >600 patients. Illumina's accelerator program provides resources and expertise for genomics-focused startups.
• Yale University / Dr. Aaron Lazorwitz LabcoreStrategic or Co-development PartnerDama Health collaborates with Yale researchers led by Dr. Aaron Lazorwitz (Medical Director and co-founder). Dama works with Yale's clinical and bioinformatics team to design IRB-ready women's health studies. Dr. Lazorwitz conducts pioneering pharmacogenomic research on hormone metabolism at Yale. His lab is publishing GWAS study findings on etonogestrel implant users and launching new studies on oral contraceptive pills.
• University City Science Center (Philadelphia)minorStrategic or Co-development PartnerDama Health participated in the University City Science Center's Capital Readiness Program in Philadelphia to prepare for US market entry. The program provided strategic positioning support and networking opportunities in the Philadelphia ecosystem, contributing to the company's decision to establish US headquarters in the region.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Midi Health: Midi Health is a virtual care clinic focused on women's midlife hormonal health, including perimenopause and menopause. Highly comparable to Dama Health because both target hormone-related clinical decision support for women, with Midi emphasizing treatment delivery and Dama emphasizing assessment + decision support tooling for clinicians.
• Maven Clinic: Maven Clinic is a digital women's and family health platform offering virtual care across fertility, pregnancy, postpartum, and menopause. Directly comparable as a B2B2C women's health platform selling into employers and health plans with provider-led care models, overlapping with Dama's enterprise sales motion into clinical practices.
• Tia: Tia operates women's health primary care clinics integrating in-person and virtual care with a focus on whole-person women's healthcare. Comparable to Dama as both target the OB/GYN and primary care experience and are pursuing evidence-based, personalized care delivery models in women's health.
• Evernow: Evernow is a virtual clinic specializing in perimenopause and menopause treatment with evidence-based hormone therapy prescribing. Directly comparable to Dama's menopause-focused module of Dama Assist and overlaps in target patient and clinician workflows.

Emerging players

• Allara Health: Allara Health is a virtual care platform for women with hormonal and metabolic conditions such as PCOS. Comparable to Dama because both address women's hormone-related conditions with personalized, evidence-based clinical care models, though Allara focuses on PCOS while Dama spans contraception, perimenopause, and menopause.
• Natural Cycles: Natural Cycles is an FDA-cleared digital contraceptive app using algorithmic fertility tracking. Comparable to Dama because both operate in the contraception/women's hormone health category and emphasize personalized, data-driven approaches to reproductive health decisions.
• Caraway Health: Caraway Health is a digital health company providing integrated mental, physical, and reproductive healthcare for college-age women. Comparable to Dama because both are women's health-focused platforms combining technology and clinical care to deliver personalized, evidence-based services.

Broad incumbents

• Tempus AI: Tempus is a precision medicine AI platform that integrates clinical and molecular data to support treatment decisions across multiple therapeutic areas. Comparable to Dama in the precision-medicine AI decision-support category, though Tempus is oncology-centric and broader in scope while Dama focuses specifically on women's hormone health.
• Myriad Genetics: Myriad Genetics is a molecular diagnostics company offering genetic tests used to guide treatment decisions across multiple therapeutic areas. Comparable to Dama in the pharmacogenomics category and in leveraging genetic data for clinical decision support, though Myriad is a much larger established player with a broader test menu.
• Oracle Health (Cerner): Oracle Health (formerly Cerner) provides enterprise EHR and clinical decision support systems used by large hospital systems and clinics globally. Comparable to Dama because both deliver clinical decision support integrated with EMR workflows; Oracle represents the dominant incumbent platform Dama must integrate with and compete against for decision-support mindshare.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/damahealth?lang=en
• LinkedInlinkedin.com/company/dama-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dama Health